Bayer Pays $97.5M To Settle Kickback Allegations

After a five-year federal investigation, Bayer HealthCare LLC has agreed to pay the U.S. Department of Justice $97.5 million plus interest to settle allegations that it paid kickbacks to diabetes products...

Already a subscriber? Click here to view full article